Molecular biomarkers of dysplasia and cancer in inflammatory bowel disease
The exon-level biomarker SLC39A14 has organ-confined cancer-specificity in colorectal cancer.
Int J Cancer 2012 Sep;131(6):1479-85. Epub 2012 jan 11
Evaluation of disease activity in IBD at the time of diagnosis by the use of clinical, biochemical, and fecal markers.
Scand J Gastroenterol 2011 Sep;46(9):1081-91. Epub 2011 mai 30
The distribution of chromosomal and microsatellite instability in colorectal cancers related to inflammatory bowel disease
Journal of Clinical Oncology 2013 ;Volum 31.(15) Suppl. may 20
Large scale genomic instability in patients with colorectal cancer in inflammatory bowel disease. Association with clinicohistol
Digestive Disease Week; 2011-05-07 - 2011-05-10
Widespread but not localized neoplasia in inflammatory bowel disease worsens the prognosis of colorectal cancer
Inflamm Bowel Dis 2010; 16:474-81